Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Regular insulin

From Wikipedia, the free encyclopedia
Short-acting insulin formulation

Pharmaceutical compound
Regular insulin
A vial of regular human insulin
Clinical data
Trade namesHumulin R, Novolin R, Actrapid, others[1][2]
Other namesinsulin injection (soluble),[2] neutral insulin,[2] regular human insulin, human insulin (regular), Toronto insulin
BiosimilarsMyxredlin[3]
AHFS/Drugs.comMonograph
MedlinePlusa682611
License data
Routes of
administration
Subcutaneous,intramuscular,intravenous[2]
ATC code
Legal status
Legal status
Pharmacokinetic data
Onset of action30 minutes
Duration of action8 hours
Identifiers
CAS Number
ChemSpider
  • none
UNII

Regular insulin, also known asneutral insulin andsoluble insulin, is a type ofshort-actingmedical insulin.[2] It is used to treattype 1 diabetes,type 2 diabetes,gestational diabetes, and complications ofdiabetes such asdiabetic ketoacidosis andhyperosmolar hyperglycemic states.[5] It is also used along withglucose to treathigh blood potassium levels.[6] Typically it is given byinjection under the skin, but may also be used byinjection into a vein ormuscle.[2] Onset of effect is typically in 30 minutes and it typically lasts for 8 hours.[5]

The common side effect islow blood sugar.[5] Other side effects may include pain or skin changes at the sites of injection,low blood potassium, andallergic reactions.[5] Use duringpregnancy is relatively safe for the baby.[5] Regular insulin can be made from thepancreas of pigs or cows.[2] Human versions can be made either by modifying pig versions orrecombinant technology.[2]

Insulin was first used as a medication inCanada byCharles Best andFrederick Banting in 1922.[7] It is on theWorld Health Organization's List of Essential Medicines.[8] In 2017, it was the 209th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[9] Versions are also available mixed with longer-acting versions of insulin, such asNPH insulin.[2] In 2020, the combination of human insulin with insulin isophane was the 246th most commonly prescribed medication in the United States, with more than 2 million prescriptions.[10][11]

Medical uses

[edit]

Regular insulin is used for the long-term management of diabetes.[5] It is the treatment of choice for the two diabetic emergenciesdiabetic ketoacidosis andhyperosmolar hyperglycemic states.[5] It may also be used in combination with glucose to lower potassium levels in those withhyperkalemia.[6]

Side effects

[edit]

Side effects may include:low blood sugar levels, skin reactions at the site of injection andlow potassium levels among others.[5]

Manufacture

[edit]

Humulin, onebrand name for a group of biosynthetic humaninsulin products, is synthesized in a laboratory strain ofEscherichia coli bacteria which has been genetically altered withrecombinant DNA to produce biosynthetic human insulin. Humulin R consists of zinc-insulin crystals dissolved in a clear fluid.[citation needed]

Formulations

[edit]

It is sold by many manufacturers in a number of different forms.

By Eli Lilly these include:[citation needed]

  • Humulin R (REGULAR human insulin injection [rDNA origin]) is a short-acting insulin that has a relatively short duration of activity as compared with other insulins.
  • Humulin R Regular U-500 (Concentrated) insulin human injection, USP (rDNA Origin) is a stronger concentration (500 units/mL) of Humulin R.
  • Humulin 70/30 (70% humaninsulin isophane suspension, 30% human insulin injection [rDNA origin]) is a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin
  • Humulin 50/50 (50% humaninsulin isophane suspension, 50% human insulin injection [rDNA origin]) is a mixture insulin. It is an intermediate-acting insulin combined with the onset of action of Humulin R.

In UK these include:[12]

  • Actrapid
  • Humulin S
  • Insuman Rapid

References

[edit]
  1. ^"insulin regular human (OTC) – Humulin R, Novolin R".Archived from the original on 16 December 2014. Retrieved1 December 2014.
  2. ^abcdefghiBritish national formulary : BNF 69 (69th ed.). British Medical Association. 2015. p. 464472.ISBN 9780857111562.
  3. ^ab"Summary Basis of Decision - Myxredlin".Health Canada. 23 October 2014. Retrieved23 February 2023.
  4. ^"Humulin R U-500- insulin human injection, solution Humulin R U-500 Kwikpen- insulin human injection, solution".DailyMed. 27 June 2022. Retrieved23 February 2023.
  5. ^abcdefghAmerican Society of Health-System Pharmacists."Insulin Human".drugs.com.Archived from the original on 22 October 2016. Retrieved1 January 2017.
  6. ^abMahoney BA, Smith WA, Lo DS, Tsoi K, Tonelli M, Clase CM (April 2005)."Emergency interventions for hyperkalaemia".The Cochrane Database of Systematic Reviews.2005 (2): CD003235.doi:10.1002/14651858.CD003235.pub2.PMC 6457842.PMID 15846652.
  7. ^Fleishman JL, Kohler JS, Schindler S (2009).Casebook for The Foundation a Great American Secret. New York: PublicAffairs. p. 22.ISBN 978-0-7867-3425-2.Archived from the original on 18 January 2017.
  8. ^World Health Organization (2019).World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization.hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  9. ^"Insulin Human - Drug Usage Statistics".ClinCalc. Retrieved11 April 2020.
  10. ^"The Top 300 of 2020".ClinCalc. Retrieved7 October 2022.
  11. ^"Insulin Human; Insulin Isophane Human - Drug Usage Statistics".ClinCalc. Retrieved7 October 2022.
  12. ^"Human Insulin - Types, Production, Action, History". Retrieved17 November 2017.
Oraldiabetes medication,insulins andinsulin analogues, and other drugs used in diabetes (A10)
fast-acting
short-acting
long-acting
ultra-long-acting
inhalable
  • Exubera
  • Afrezza
Oral
Non-insulins
Insulin sensitizers
Biguanides
TZDs/"glitazones" (PPAR)
Dual PPAR agonists
Amylin analogues andDACRAs
Secretagogues
K+ATP
Sulfonylureas
Meglitinides/"glinides"
GLP-1 receptor agonists
GLP1 poly-agonist peptides
DPP-4 inhibitors/"gliptins"
Other
Aldose reductase inhibitors
Alpha-glucosidase inhibitors
SGLT2 inhibitors/"gliflozins"
Other
Combinations
Portal:
Retrieved from "https://en.wikipedia.org/w/index.php?title=Regular_insulin&oldid=1240716764"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp